Y-mAbs Therapeutics, Inc.
YMAB
$5.04
-$0.2262-4.29%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.20M | -6.79M | -7.00M | -9.25M | -6.63M |
| Total Depreciation and Amortization | 71.00K | 102.00K | 121.00K | 153.00K | 159.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.53M | 6.04M | 3.02M | 3.67M | 4.34M |
| Change in Net Operating Assets | -4.32M | -1.22M | -6.80M | 5.72M | -1.35M |
| Cash from Operations | -6.91M | -1.87M | -10.67M | 298.00K | -3.48M |
| Capital Expenditure | -127.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -127.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 114.00K | 986.00K | 979.00K | 1.76M | 588.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 114.00K | 986.00K | 979.00K | 1.76M | 588.00K |
| Foreign Exchange rate Adjustments | -- | -4.00K | 2.00K | 1.00K | 1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.92M | -888.00K | -9.68M | 2.06M | -2.89M |